Simplexa CMV

Herpesvirus (HHV-5) - cytomegalovirus · class IV · Until 28/11/2026

Registration no.
10259610130
Process no.
25351602818201171
Status
Until 28/11/2026
Device type
Herpesvirus (HHV-5) - cytomegalovirus (HERPES VÍRUS (HHV 5) - CITOMEGALOVÍRUS)
Risk class
IV
Registration holder
MEDIVAX INDÚSTRIA E COMÉRCIO LTDA CNPJ 68.814.961/0001-73 · 259 registrations
Manufacturer
DIASORIN MOLECULAR LLC · United States
Published
28/11/2011
Valid until
28/11/2026
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other herpesvirus (hhv-5) - cytomegalovirus registrations (2 in total, see all)

ProductClass HolderPublishedStatus
Simplexa CMV - Quantitation Standards
10259610129
IV MEDIVAX INDÚSTRIA E COMÉRCIO LTDA 28/11/2011 Until 28/11/2026